Sort
82,697 grants matching “vaccine development”
Task A80: Advanced Small Animal Models for the Testing of Candidate Interventions against Mycobacteria
$3,086,647Angelo Izzo · Colorado State University · N01 · FY2016 · AI
China's Integrated Programs for Research on AIDS
$3,085,741National Center/Aids/Std Control/Prevent · U19 · FY2002 · AI
Providence/Boston Center for AIDS Research (CFAR)
$3,084,858Susan Cu-Uvin · Miriam Hospital · P30 · FY2020 · AI
Structure-function studies of alpha-and flaviviruses
$3,082,404Purdue University West Lafayette · P01 · FY2005 · AI
Infectious Diseases Research Technologies Core - RML
$3,082,286Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2010 · AI
Targeting mTOR and CD40 Pathways for Adjuvanting HIV Vaccines
$3,079,095Rama Rao Amara · Emory University · P01 · FY2013 · AI
Nonhuman primate scientific research support component
$3,078,968Sampa Santra · Duke University · UM1 · FY2016 · AI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,078,872Jerrold J. Ellner · Boston Medical Center · U19 · FY2016 · AI
NIAID VIROLOGY QUALITY ASSURANCE
$3,078,328James Bremer · Rush University Medical Center · N01 · FY2015 · AI
TCR-dependent and epigenetic mechanisms guiding influenza-specific CD4+ T cell responses in the lung
$3,078,308Jeffrey Scott Hale · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,077,917Anna Karolina Palucka · Baylor Research Institute · U19 · FY2011 · AI
The Immunobiology of Marrow Allografts for Leukemia
$3,076,095Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
B Cell Biology
$3,076,055Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Construction/SEBLAB/Regional Biocontainment Laboratory
$3,075,560University Of Alabama At Birmingham · UC6 · FY2005 · AI
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$3,075,283Richard Childs · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
$3,074,366Jeanne M Marrazzo · University Of Alabama At Birmingham · N01 · FY2022 · AI
Animal Medicine COVID Support
$3,073,765Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIG · FY2020 · AI
MULTICENTER AIDS COHORT STUDY
$3,073,407John P Phair · Howard Brown Health Center · U01 · FY2007 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,072,123Donald K Milton · Univ Of Maryland, College Park · U19 · FY2024 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,072,035Donald K Milton · Univ Of Maryland, College Park · U19 · FY2023 · AI
Development of vaccines to bacterial diseases found especially in children
$3,071,596John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Activation of Macrophages in Human Autoimmune Diseases
$3,071,328Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2025 · AI
MALARIA VACCINES: CLINICAL RESEARCH AND TRIAL SITES IN ENDEMIC AREAS
$3,070,900Kwadwo Koram · Noguchi Memorial Institute / Medical Res · N01 · FY2011 · AI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$3,069,641Adriana H Tremoulet · University Of California, San Diego · P50 · FY2022 · HD
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$3,068,402Bali Pulendran · Emory University · U19 · FY2012 · AI